These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 28131096)

  • 1. TP53INP2-related basal autophagy is involved in the growth and malignant progression in human liposarcoma cells.
    Hu Y; Li X; Xue W; Pang J; Meng Y; Shen Y; Xu Q
    Biomed Pharmacother; 2017 Apr; 88():562-568. PubMed ID: 28131096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential cytotoxicity of bortezomib toward highly malignant human liposarcoma cells via suppression of MDR1 expression and function.
    Hu Y; Wang L; Wang L; Wu X; Wu X; Gu Y; Shu Y; Sun Y; Shen Y; Xu Q
    Toxicol Appl Pharmacol; 2015 Feb; 283(1):1-8. PubMed ID: 25576094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated fibroblasts promote the proliferation and decrease the doxorubicin sensitivity of liposarcoma cells.
    Harati K; Daigeler A; Hirsch T; Jacobsen F; Behr B; Wallner C; Lehnhardt M; Becerikli M
    Int J Mol Med; 2016 Jun; 37(6):1535-41. PubMed ID: 27082154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SBF-1 preferentially inhibits growth of highly malignant human liposarcoma cells.
    Chen W; Qian X; Hu Y; Jin W; Shan Y; Fang X; Sun Y; Yu B; Luo Q; Xu Q
    J Pharmacol Sci; 2018 Dec; 138(4):271-278. PubMed ID: 30415825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of TP53INP2 Promotes Apoptosis in Clear Cell Renal Cell Cancer via Caspase-8/TRAF6 Signaling Pathway.
    Li X; Hu D; Li Y; Luo Y; Liang B; Yu K; Xiong W; Zuo D
    J Immunol Res; 2022; 2022():1260423. PubMed ID: 35615533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53INP2 mediates autophagic degradation of ubiquitinated proteins through its ubiquitin-interacting motif.
    Xu Y; Wan W
    FEBS Lett; 2019 Aug; 593(15):1974-1982. PubMed ID: 31155706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TP53INP2 protein is required for autophagy in mammalian cells.
    Nowak J; Archange C; Tardivel-Lacombe J; Pontarotti P; Pébusque MJ; Vaccaro MI; Velasco G; Dagorn JC; Iovanna JL
    Mol Biol Cell; 2009 Feb; 20(3):870-81. PubMed ID: 19056683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53INP2 is the new guest at the table of self-eating.
    Nowak J; Iovanna JL
    Autophagy; 2009 Apr; 5(3):383-4. PubMed ID: 19145107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is TP53INP2 a critical regulator of muscle mass?
    Sala D; Zorzano A
    Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):234-9. PubMed ID: 25769060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase 2b blocks cell differentiation in human liposarcoma cells.
    Wang L; Li W; Yang Y; Hu Y; Gu Y; Shu Y; Sun Y; Wu X; Shen Y; Xu Q
    Life Sci; 2014 Mar; 99(1-2):37-43. PubMed ID: 24508653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy-regulating TP53INP2 mediates muscle wasting and is repressed in diabetes.
    Sala D; Ivanova S; Plana N; Ribas V; Duran J; Bach D; Turkseven S; Laville M; Vidal H; Karczewska-Kupczewska M; Kowalska I; Straczkowski M; Testar X; Palacín M; Sandri M; Serrano AL; Zorzano A
    J Clin Invest; 2014 May; 124(5):1914-27. PubMed ID: 24713655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer.
    Chittaranjan S; Bortnik S; Dragowska WH; Xu J; Abeysundara N; Leung A; Go NE; DeVorkin L; Weppler SA; Gelmon K; Yapp DT; Bally MB; Gorski SM
    Clin Cancer Res; 2014 Jun; 20(12):3159-73. PubMed ID: 24721646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin α6(high) cell population functions as an initiator in tumorigenesis and relapse of human liposarcoma.
    Wang L; Wang L; Gu Y; Shu Y; Shen Y; Xu Q
    Mol Cancer Ther; 2011 Dec; 10(12):2276-86. PubMed ID: 21980129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nelfinavir induces liposarcoma apoptosis and cell cycle arrest by upregulating sterol regulatory element binding protein-1.
    Chow WA; Guo S; Valdes-Albini F
    Anticancer Drugs; 2006 Sep; 17(8):891-903. PubMed ID: 16940799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.
    Fukuda T; Oda K; Wada-Hiraike O; Sone K; Inaba K; Ikeda Y; Miyasaka A; Kashiyama T; Tanikawa M; Arimoto T; Kuramoto H; Yano T; Kawana K; Osuga Y; Fujii T
    Gynecol Oncol; 2015 Jun; 137(3):538-45. PubMed ID: 25842161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines.
    Weng J; Wang C; Wang Y; Tang H; Liang J; Liu X; Huang H; Hou J
    Oral Oncol; 2014 Oct; 50(10):983-90. PubMed ID: 25096824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6, C/EBP-β and PPAR-γ expression correlates with intramuscular liposarcoma growth in mice: The impact of voluntary physical activity levels.
    Assi M; Kenawi M; Ropars M; Rébillard A
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1026-1032. PubMed ID: 28668397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bifunctional role of TP53INP2 in transcription and autophagy.
    Xu Y; Wan W
    Autophagy; 2020 Jul; 16(7):1341-1343. PubMed ID: 31931658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanistic study on the metastasis inducing function of FUS-CHOP fusion protein in liposarcoma.
    Patil N; Ahmed Kabeer Rasheed S; Abba M; Hendrik Leupold J; Schwarzbach M; Allgayer H
    Int J Cancer; 2014 Jun; 134(12):2808-19. PubMed ID: 24285420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
    Ding ZB; Hui B; Shi YH; Zhou J; Peng YF; Gu CY; Yang H; Shi GM; Ke AW; Wang XY; Song K; Dai Z; Shen YH; Fan J
    Clin Cancer Res; 2011 Oct; 17(19):6229-38. PubMed ID: 21825039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.